Analysis of Onset Mechanisms of a Sphingosine 1-Phosphate Receptor Modulator Fingolimod-Induced Atrioventricular Conduction Block and QT-Interval Prolongation-Reference-Cited by-同舟云学术

Analysis of Onset Mechanisms of a Sphingosine 1-Phosphate Receptor Modulator Fingolimod-Induced Atrioventricular Conduction Block and QT-Interval Prolongation

Published:2014-11 Issue:1 Volume:281 Page:39-47
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

Yagi Yukihiro,Nakamura Yuji,Kitahara Ken,Harada Takuma,Kato Kazuhiko,Ninomiya Tomohisa,Cao Xin,Ohara Hiroshi,Izumi-Nakaseko Hiroko,Suzuki Kokichi,Ando Kentaro,Sugiyama Atsushi

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference35 articles.

1. Novel immunomodulator FTY720 is phosphorylated in rats and humans to form a single stereoisomer. Identification, chemical proof, and biological characterization of the biologically active species and its enantiomer;Albert;J. Med. Chem.,2005

2. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis;Cohen;N. Engl. J. Med.,2010

3. Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results;Comi;Mult. Scler.,2010

4. The bee venom peptide tertiapin underlines the role of I(KACh) in acetylcholine-induced atrioventricular blocks;Drici;Br. J. Pharmacol.,2000

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preventing and managing cardiovascular events in patients with inflammatory bowel diseases treated with small-molecule drugs, an international Delphi consensus;Digestive and Liver Disease;2024-08

2. Review article: Risk of cardiovascular events in patients with inflammatory bowel disease receiving small molecule drugs;Alimentary Pharmacology & Therapeutics;2023-04-10

3. A Randomized, Double‐Blind, Parallel Design Thorough QT Study With a Nested Crossover to Compare the Cardiac Safety of Amiselimod With Placebo and Positive Control in Healthy Volunteers;Clinical Pharmacology in Drug Development;2023-01-28

4. Is there a connection between HDL and atrial fibrillation?;Journal of Clinical Lipidology;2022-07

5. Stroke risk in multiple sclerosis: a critical appraisal of the literature;International Journal of Neuroscience;2022-04-03